Related Experiment Videos
Does almitrine bismesylate improve V/Q matching? An animal study
European Journal of Respiratory Diseases. Supplement
|January 1, 1983
Summary
Almitrine bismesylate causes pulmonary vasoconstriction in normoxia and variable effects in hypoxia. Its impact on ventilation/perfusion matching in lung disease remains uncertain.
Area of Science:
- Pulmonary pharmacology and physiology
- Respiratory medicine
Background:
- Hypoxic lung disease is characterized by pulmonary vasoconstriction and ventilation/perfusion (V/Q) mismatch.
- Almitrine bismesylate is a drug investigated for its effects on respiratory function.
Purpose of the Study:
- To investigate the pulmonary vascular and ventilatory actions of almitrine bismesylate in various animal models simulating hypoxic lung disease.
- To determine if almitrine bismesylate improves V/Q matching in hypoventilated lungs.
Main Methods:
- Studies were conducted in ferrets, rats, cats, and dogs using in vivo and isolated lung preparations.
- Hypoxia or hypoventilation was induced to simulate disease conditions.
- Ventilatory responses were measured in chronically hypoxic rats.
Main Results:
- Almitrine bismesylate induced vasoconstriction in normoxia and a biphasic response (constriction then dilation) in hypoxia or hypoventilation across species.
- No improvement in V/Q mismatch was observed in hypoventilated lungs.
- In hypoxic rats, almitrine bismesylate increased tidal volume but not respiratory rate.
Conclusions:
- Almitrine bismesylate exhibits complex pulmonary vascular effects dependent on oxygen levels.
- The drug's ability to improve V/Q matching in chronic obstructive pulmonary disease patients requires further investigation into its vascular versus ventilatory effects.